Interestingly, a recent study revealed an opposing role of Epac in melanoma progression, where Epac, via Rap1, plays a pro-survival role in primary melanoma and switches to an anti-survival role in metastatic melanoma [97]. Here, RAPGEF4 is linked to metastatic melanoma.